Funder: Pfizer Inc.
Due Dates: June 18, 2026 (Full application submission deadline, 5:00 PM ET)
Funding Amounts: Up to $6,000 per award for local program costs; Visiting Professor travel/honoraria covered separately; ~12 sites funded
Summary: Supports organizations to host Visiting Professorships focused on shared decision making and new therapies in hemophilia care.